Sarcoidosis

Sarcoidosis (pronounced SAR-COY-DOE-SIS) is an inflammatory disease characterized by the formation of granulomas—tiny clumps of inflammatory cells—in one or more organs of the body. When the immune system goes into overdrive and too many of these clumps form, they can interfere with an organ's structure and function. When left unchecked, chronic inflammation can lead to fibrosis, which is the permanent scarring of organ tissue. This disorder affects the lungs in approximately 90% of cases, but it can affect almost any organ in the body. Despite increasing advances in research, sarcoidosis remains difficult to diagnose with limited treatment options and no known cure.

Today's episode we are speaking with Frank Rivera from New York.

Frank founded Sarcoidosis of Long Island in 2012. In 2011 Frank was diagnosed with Sarcoidosis after being misdiagnosed with lung cancer for 7 years prior. Since opening Sarcoidosis of Long Island he has been a local, state and federal advocate for Sarcoidosis. Frank strives to raise awareness for Sarcoidosis nationally, but specifically in the government sector. He has represented the Rare and Sarcoidosis community as a speaker at two Congressional briefings for Sarcoidosis.

Frank is also a WEGO Health Patient Leader, the National Ambassador for Foundation for Sarcoidosis Research, a Global Genes RARE Foundation Alliance Member & Advocate, an ambassador for The EveryLife Foundation and a Working Group Member and Long Island Liaison for National Organization for Rare Diseases (NORD). Named RUGD Ambassador for Illumina October 2017. Frank was named "Person of the Year " in Brookhaven Town.

Frank organized RareNY in 2016, to raise awareness for Rare Diseases in the state of New York. He organized "A Day for Rare Diseases" on October 15th, 2016 in Long Island NY, in partnership with Global Genes, to raised awareness for all 7000+ rare diseases. In recognition of Frank's efforts, Suffolk County and the town of Brookhaven officially declared October 15th "A Day for Rare Diseases".